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Abstract
Background: Hypophosphatasia (HP) is characterized by a genetic defect in the tissue-nonspecific
alkaline phosphatase (TNSALP) gene and predominantly an autosomal recessive trait. HP patients
suffer from reduced bone mineralization. Biochemically, elevated concentrations of substrates of
TNSALP, including pyridoxal-5'-phosphate and inorganic pyrophosphate occur in serum, tissues
and urine. The latter has been associated with chronic inflammation and hyperprostaglandinism.
Case presentation: We report on 2 affected children presenting with multifocal inflammatory
bone lesions mimicking malignancy: A 6 years old girl with short stature had been treated with
human growth hormone since 6 months. Then she started to complain about a painful swelling of
her left cheek. MRI suggested a malignant bone lesion. Bone biopsy, however, revealed chronic
inflammation. A bone scan showed a second rib lesion. Since biopsy was sterile, the descriptive
diagnosis of chronic non-bacterial osteomyelitis (CNO) was established. The diagnostic tests
related to growth failure were repeated and subsequent analyses demonstrated a molecular defect
in the TNSALP gene. The second girl (10 years old) complained about back pain after she had fallen
from her bike. X rays of her spine revealed compressions of 2 thoracic vertebrae. At first these
were considered trauma related, however a bone scan did show an additional lesion in the right 4th
rib. A biopsy of this rib revealed a sterile lympho- plasmocytoid osteomyelitis suggesting multifocal
CNO. Further analyses did show a decreased TNSALP in leukocytes and elevated pyridoxal
phosphate in plasma, suggesting a heterozygous carrier status of HP.
Conclusion: Chronic bone oedema in adult HP and chronic hyper-prostaglandinism in childhood
HP do suggest that in some HP patients bone inflammation is present in conjunction with the
metabolic defect. Sterile multifocal osteomyelitis could be demonstrated. Non-steroidal anti-
inflammatory treatment achieved complete remission. These cases illustrate chronic inflammation
of the bone as a new feature of HP.
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Background
Hypophosphatasia (HP) is characterized by a genetic
defect in the gene of the tissue-nonspecific alkaline phos-
phatase TNSALP [1-3]. There is clinical variability of the
HP phenotype: 5 major subtypes (perinatal, infantile,
childhood, adult and odontohypophosphatasia) have
been described [4]. Biochemical [5] and molecular data
[6-9] indicate that the severity of the molecular genetic
alterations and subsequently levels of TNSALP are major
determinants of the clinical phenotype. Childhood HP
presents after the first year of life with rickets causing a
short stature, delayed walking and a waddling gait due to
bone deformities (genua vara or valga) and chronic skele-
tal pain. Clinical variability of childhood hypophosphata-
sia includes short stature, premature loss of teeth,
disturbances of gait, muscle weakness, signs of muscle
inflammation and chronic pain located mainly in the
lower legs [4]. We have previously described the presence
of hyperprostaglandinism in these children, which seems
to be a sequel of accumulating pyrophosphate crystals
especially in soft tissues [10,11]. Non-steroidal anti-
inflammatory agents have been effective in treating
chronic pain in these children [10]. So far there have been
few reports stating that the bone can be inflamed chroni-
cally in HP. Therefore, co-presentation of chronic non-
bacterial osteomyelitis (CNO, CRMO) and hypophos-
phatasia had to be considered in our patients. The term
CNO is reserved for a clinical entity affecting mainly ado-
lescents. It can have a uni- or multifocal occurrence [12].
Differential diagnosis included several entities including
bone malignancies like osteosarcoma, rhabdomyosar-
coma, Ewing's sarcoma and histiocytosis [13]. In this
regard it is of importance, that multifocal CNO can also
cause hyperostosis [12] and osteolytic lesions. Thus, it can
be misdiagnosed as malignancy and vice versa [14]. A
direct link between HP and sterile osteomyelitis has not
been elucidated so far. An inflammatory process second-
ary to the metabolic defect in HP might be involved [10].
Case presentation
Case 1
Since birth the child had always been of short stature and
low body weight. Growth dynamics showed a constant
development of the length along a curve 2 cm below the
third percentile. Her weight had increased along the third
or slightly below the third percentile during the first six
years of life. The genetically determined and proposed
length was 1.55 meter (3rd – 10th percentile) (figure 1).
A detailed diagnostic workup repetitively revealed a nor-
mal concentration of IgF1 (insulin-like growth factor), IgF
BP-3 (insulin-like growth factor binding protein). How-
ever, stimulation tests using L-arginine and insulin
revealed an insufficient rise in human growth hormone
(HGH). Therefore a hypothalamic insufficiency was diag-
nosed. A subsequent cranial MRI was unremarkable (fig-
ure 1b). Other reasons for short stature including thyroid
insufficiency, cystic fibrosis, chromosomal abnormalities
and celiac disease were excluded. Due to a 2 years retarda-
tion of the bone age a constitutional retardation of growth
also was discussed. Based on two insufficient stimulations
of HGH growth hormone therapy was instituted at a
standard regimen. Two months later a swelling of the left
cheek was noted in addition to local pain while chewing
(figure 1c). Dental and ear-nose-throat evaluation were
unremarkable. An outpatient antibiotic therapy was
started, which did not improve the swelling. Therefore the
child was admitted 5 months after HGH treatment had
been started (figure 1d). There were no elevated inflam-
matory parameters (ESR, CRP, leukocytes). A differential
blood count did not show signs of malignancy. Further
workup revealed normal levels of beta-HCG (human cho-
riogonadotropin), neuron specific enolase and angi-
otensin converting enzyme. HLA B 27 was absent. MRI
showed bone oedema and a diffuse oedematous change
of the os zygomaticum surrounding tissue (figure 1e). A
cranial computed tomography revealed sclerotic and
hyperostotic changes of the os zygomaticum adjacent to
the maxillary cavity (figure 1f). The cancellous part and
the outer compacta, however, showed osteolysis. Differ-
ential diagnosis included bone malignancy, eosinophilic
granuloma and chronic inflammation. A technetium
bone scan revealed an enhanced uptake in this lesion in
addition to another lesion of the right fourth rip (figure
1h). Conventional X-ray of the right hemithorax revealed
hyperostosis of the 4th rib (figure 1g). Again malignancy
was suspected. To further clarify the diagnosis biopsies
were performed including a biopsy of the affected rib and
a biopsy of the cheek lesion. Histologically a chronic
inflammatory reaction affecting the bone, the periost and
the surrounding tissue consisting of predominantly lym-
phocytes was diagnosed and malignancy was excluded. A
detailed microbial workup was performed including
eubacteria, mycobacteria and fungi. An universal
polymerase chain reaction using primers amplifying
ribosomal RNA did not reveal a product [15].
After exclusion of malignancy and an infectious aetiology
the descriptive diagnosis of chronic non-bacterial multifo-
cal osteomyelitis (CNO) was made. Since this diagnosis
usually affects adolescents other causes were discussed.
Despite of an intensive literature research it stayed unclear
whether growth hormone treatment can contribute to a
chronic inflammatory bone process. During this new re-
evaluation relatively low serum levels of previously docu-
mented total alkaline phosphatase levels (120, 102, 93,
131 U/l) were noted. Recently, the definition of the lower
normal levels (37°C IFCC method) has become difficult
to jugde. Compared to a cohort of genetically diagnosed
childhood hypophosphatasia patients [16,11] these levels
were considered borderline. Therefore we performed aBMC Pediatrics 2007, 7:3 http://www.biomedcentral.com/1471-2431/7/3
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clinical synopsis of a 6 years old girl with a history of short stature Figure 1
clinical synopsis of a 6 years old girl with a history of short stature. Figure 1a shows the patient at the time of sus-
pected growth hormone releasing hormone failure. 2 months after growth hormone therapy started a painful swelling of the 
cheek was noted (figure 1c) which worsened at the time of presentation 3 months later (figure 1d). Initial magnetic resonance 
imaging (MRI) was normal (figure 1b: T2-weighted transversal image (slice thickness 5 mm)). Subsequent MRI 5 months later 
did show a diffuse bone lesion affecting the os zygomaticum and involving surrounding soft tissue (figure 1e: Fat saturated 
strongly T2-weighted transversal image (slice thickness 5 mm)). Malignancy could not be excluded. Computed tomography 
revealed hyperostosis in addition to osteolysis (arrows) of the cortical bone (figure 1f). Conventional x-ray of the right hemith-
orax showed hyperostosis of the anterior 4th rip (figure 1g). Technetium 99m-MDP bone scan showed the involvement of the 
os zygomaticum and the clinically silent costal lesion (figure 1h). 1 year of non-steroidal anti-inflammatory treatment induced 
clinical remission (figure 1i). MRI did show a very small signal elevation in the area of the biopsy (figure j: Fat saturated strongly 
T2-weighted transversal image (slice thickness 5 mm)).BMC Pediatrics 2007, 7:3 http://www.biomedcentral.com/1471-2431/7/3
Page 4 of 7
(page number not for citation purposes)
specific measurement of the tissue non-specific alkaline
phosphatase in leukocytes, which were below normal (1.2
nmol/min/mg Protein; normal: 2 – 18) [16]. In addition,
pyridoxal phosphate in the plasma was significantly ele-
vated (97 ng/ml; normal: 5 – 30 ng/ml). Therefore the
diagnosis of a mild form of hypophosphatasia was made.
Further genetic diagnostic workup revealed the presence
of a heterozygous mutation R374C (c.1171C>T) which
was previously described in patients with various forms of
hypophosphatasia [8,9]. The mutation is supposed to
have a severe effect in view of site-directed mutagenesis
experiments and phenotypes of some patients. In this
family, the mutation is from maternal origin, since it was
found in the mother's genome also. Despite of sequencing
the whole coding sequence and intron/exon borders, we
did not find any other mutation. In addition we found a
number of intronic and exonic polymorphisms
(c.330C>T (S93S), c787T>C (Y246H), c.862+20G>T,
c862+51G>A, c862+58C>T, c.863-7T>C, c.863-12C>G,
c.876A>G(P275P), c.1565T>C(V505A)). Quantitative
Multiplex PCR of short fragments of exons 1,3,5,7,9 and
12 did not give evidence of any large deletion in the ALPL
gene.
Case 2
The second girl (10 years old) complained about back
pain after she had fallen from her bike. She had grown
normal along the 50th height percentile. X rays of her
spine revealed oedematous changes of 3 and compres-
sions of 2 thoracic vertebrae (# 9, 11). At first these were
considered trauma related, however, especially posterior
oedematous changes of the 8th vertebra were considered
not to be typical sequels of a trauma (figure figure 2c–e).
In addition, a technetium bone scan did show an addi-
tional lesion in the right 4th rib (figure 2a,b). The rib
lesion was also analysed by MRI of the thorax. It did show
a strong T2/TIRM/STIR signal. Thus Langerhans' cell histi-
ocytosis was suspected at that time. A biopsy of this rib,
however, revealed a sterile lympho- plasmocytoid osteo-
myelitis suggesting multifocal CNO. There were no ele-
vated inflammatory parameters (ESR, CRP, leukocytes). A
differential blood count did not show signs of malig-
nancy. Further workup revealed normal serum levels of
beta-HCG (human choriogonadotropin), neuron specific
enolase, cortisol and angiotensin converting enzyme.
HLA B 27 was present. Total alkaline phosphatase levels
(401, 426, 316, 378, 185, 189 U/l) measured over time
were in the normal range. Compared to a cohort of genet-
ically diagnosed childhood hypophosphatasia patients
[16,11] these levels were considered unremarkable. How-
ever, a nephelometric measurement of the bone alkaline
phosphatase revealed a reduced level (8.9 microg/l; nor-
mal 36–80 microg/l). Therefore, a more reliable and spe-
cific measurement of the tissue non-specific alkaline
phosphatase in leukocytes was done. The result was below
normal (1.8 nmol/min/mg Protein; normal: 2 – 18) [16].
In addition, pyridoxal phosphate in the plasma was
slightly elevated (31 ng/ml; normal: 5 – 30 ng/ml), phos-
phoethanolamine excretion in the urine was normal. We
suggested that a partial defect in the TNSALP gene was
present. She may be a carrier of one severely mutated
allele of alkaline phosphatase, because slight elevation of
plasma pyridoxal levels has been demonstrated in obliga-
tory heterozygotes (parents of index patients) with severe
alleles [16]. Thus, the patient might be a carrier for the
hypophosphatasia trait. The family refused a diagnostic
genetic workup.
Based on our experience in treating hypophosphatasia
patients with non-steroidal anti-inflammatory agents
[10,11], in addition to the anti-inflammatory treatment of
chronic non-bacterial osteomyelitis patients [12] we
started a therapy using naproxen at a dose of 15 mg/kg/d
in both patients. This therapeutic protocol was approved
by the ethics committee of the University of Wuerzburg.
Follow up of patient 1
The treatment rapidly reduced clinical symptoms includ-
ing pain and soft tissue swelling (figure 1i). Parallel to this
clinical improvement subsequent MRI analysis after 3, 6
and 12 months revealed subsequent reduction of bone
marrow oedema and local gadolinium enhancement. 12
months later MRI showed almost unremarkable lesions
(figure 1j). Mild hyperostosis of the os zygomaticum was
still present after 12 months at treatment cessation. 24
months later the patient was still in remission.
Follow up of patient 2
The medication did abrogate pain completely after the
first 3 months of treatment. Parallel to this clinical
improvement subsequent MRI analysis (figure 2c–e) after
3, 6 and 12 (figure 2f–h) months revealed subsequent
reduction of bone marrow oedema and local gadolinium
enhancement. 12 months later MRI showed an unremark-
able 8th thoracic vertebra, whereas the 9th and 11th still
showed compression without sign of acute inflammation
(figure 2f–h). The rib lesion was unremarkable after 6
months of treatment. No further structural improvement
was noted after 24 months. Thus, treatment was termi-
nated.
Conclusion
These two case reports illustrate several clinical problems.
At first chronic inflammatory bone lesions can mimic
bone tumors, soft tissue tumors and haematological
malignancies including osteosarcoma, rhabdomyosar-
coma and Langerhans-cell-histocytosis [15]. Diagnostic
imaging including MRI and bone scan might not be suffi-
cient enough to make a proper diagnosis [14]. Findings in
diagnostic imaging in the two patients were not differentBMC Pediatrics 2007, 7:3 http://www.biomedcentral.com/1471-2431/7/3
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clinical synopsis of a 10 years old girl with a history of back pain Figure 2
clinical synopsis of a 10 years old girl with a history of back pain. Technetium 99m-MDP bone scan (figure 2a and b) 
shows the rib and multiple osseous spine lesions at diagnosis. Initial magnetic resonance imaging (MRI) revealed a compression 
of vertebra #9 and 11 (figure 2c: T1-weighted sagittal image (arrows); figure 2d: T1-weighted sagittal image after i.v. gadolinium 
enhancement), in addition to oedematous changes predominantly in the 8th vertebra (figure 2e: strongly T2-weighted sagittal 
image; arrow). Subsequent MRI 12 months later no longer showed oedematous changes, however the vertebral compressions 
were still present (figure 2f: T1-weighted sagittal image (arrows); figure 2g: T1-weighted sagittal image after i.v. gadolinium 
enhancement; figure 2h: strongly T2-weighted sagittal image).BMC Pediatrics 2007, 7:3 http://www.biomedcentral.com/1471-2431/7/3
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in extent and structure from a cohort of patients with
chronic osteomyelitis in whom hypophosphatasia had
been excluded [12,14]. Therefore the diagnosis often has
to be biopsy proven. However, the quality of the biopsy
depends significantly on whether representative areas of
the lesion are included. Secondly, microbial workup has
to be as detailed and as extensive as possible to exclude
rare chronic bacterial osteomyelitis and to avoid unneces-
sary long-term antibiotic treatment [15]. Thirdly, it shows
a dilemma in the care of patients with mild hypophos-
phatasia or hypophosphatasia traitors. Borderline or
slightly reduced alkaline phosphatase values might be
overlooked in clinical practice especially because the
lower reference range of alkaline phosphatase activity is
not defined precisely. In addition, hyperpostaglandinism,
which has been demonstrated in hypophosphatasia,
might contribute to chronic bone inflammation in this
disease [10,11]. It is also unclear whether growth hor-
mone therapy might also have played a role in the first
patient's inflammatory process. In addition, hypophos-
phatasia patients do show changes in their bone structure,
which can resemble vitamin D resistant rickets or osteo-
malacia clinically and on x-rays [4]. Hypophosphatasia
patients are prone to bone fractures, but bone inflamma-
tion has not been reported in conjunction with osteoma-
lacia or fractures in hypophosphatasia so far. In our cases,
even though we can not exclude a contribution of the
altered bone structure, inflammatory histologic changes
seem to be of a different, supposedly metabolic, nature
than structural bone insufficiency alone. Furthermore,
minimal and unrecognized trauma might be a trigger fac-
tor for the lesions seen in our patients. In healthy individ-
uals one would not expected that bone inflammation
might result from such a trauma. However, bone in hypo-
phosphatasia might react differently on the basis of the
primary TNSALP and secondary metabolic condition
(pyrophosphate, prostaglandins) [11]. A structurally
altered rib cage like pigeon-chest is present in some hypo-
phosphatasia patients and might lead to a repetitive min-
imal trauma at the costochondral junction. Chest
structure, however, was unremarkable in our patients. In
addition, since a solitary major rib lesion was present in
each of our patients a traumatic origin of the lesion seems
to be unlikely, because several adjacent lesions could be
expected then. Of note, even though the clavicle is affected
in CNO predominantly, rib lesions are rare in our and
other CNO cohorts [17,12,18-22].
Even though the precise aetiology of the hypophosphata-
sia patient's chronic bone inflammation is not known,
symptomatic anti-inflammatory treatment was the treat-
ment of choice and was effective.
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